Synapse News
Adapsyn Bioscience enters into strategic collaboration with Evotec
Adapsyn Bioscience Inc., a chemical bioinformatics company that discovers novel drug-like small molecules, today announced a strategic collaboration with Evotec SE. Under the collaboration, Evotec will have the opportunity to evaluate small molecules developed by Adapsyn as potential therapeutic candidates in proprietary and partnered drug
OmniaBio Groundbreaking Ceremony
Thursday, October 6, 2022, from 10:00 am to 12:00 pm in Hamilton, Ontario Mitchel Sivilotti, President of OmniaBio, and Dr. Michael May, President and CEO of CCRM, invite you to attend OmniaBio’s groundbreaking and signing ceremony. OmniaBio will be Canada’s first and largest commercial-scale contract development and manufacturing
Startups need cash, time, and connections
Alex Muggah has seen hundreds of life sciences and healthtech companies work to commercialize their innovations. If new healthcare innovations don’t integrate with existing systems, there is little to no chance of mass adoption. As Director of the Synapse Life Science Consortium, a partnership of public- and private-sector institutions in
AtomVie Global Radiopharma Inc. Announces its Spinout and Series A Financing with Avego
AtomVie Global Radiopharma Inc. (AtomVie) today announced the successful closing of its Series A financing with Avego Management, LLC (“Avego”), a healthcare investment firm. AtomVie is a global leading CDMO (Contract Development and Manufacturing Organization) for the development, manufacturing, and global distribution of
Innovative Health Diagnostics and Hamilton-based AIMA Laboratories Collaborate to Develop New, Revolutionary At-Home Test to Detect Endometriosis
Innovative Health Diagnostics (IHD), a CLIA- and FDA-certified lab that empowers every person access to accurate, clinical testing by providing testing when and where it matters most, announced today a new partnership with AIMA Laboratories (AIMA), a Hamilton-based FemTech company dedicated to developing new products that fill current gaps in
Renowned burn surgeon leaves Toronto for Hamilton to reboot General’s burn trauma unit, develop ‘skin printing’ stem cell tech, and become new VP Research at Hamilton Health Sciences
Dr. Marc Jeschke joined McMaster University as a professor of surgery, and was also recently named vice-president of research at Hamilton Health Sciences and medical director of its burns unit. The burn trauma surgeon and scientist is moving to Hamilton from Toronto to become medical director of the burn unit at the General Hospital on […]
Invest Ontario features Hamilton’s OmniaBio – Shaping the Future of Regenerative Medicine
Since the 1963 discovery of stem cells by two University of Toronto researchers, Drs. Ernest McCulloch and James Till, Ontario has been at the forefront of regenerative medicine discovery and development. Dr. Peter Zandstra C.M., Chief Scientific Officer, and Dr. Michael May, President and Chief Executive Officer of CCRM, recognized a need to
McMaster Researcher Parminder Raina Receives Order of Canada
McMaster professor Dr. Parminder Raina has been honoured as a member of the Order of Canada — one of the highest honours of merit in Canada — for his extraordinary contribution to research on aging and its impact on policy-making. Raina, also a lead investigator of the Canadian Longitudinal Study on Aging (CLSA), is among […]
McMaster Researcher Parminder Raina Receives Order of Canada
McMaster professor Dr. Parminder Raina has been honoured as a member of the Order of Canada — one of the highest honours of merit in Canada — for his extraordinary contribution to research on aging and its impact on policy-making. Raina, also a lead investigator of the Canadian Longitudinal Study on Aging (CLSA), is among […]